with type 2 diabetes: 62.7% responders and 37.3% non-responders) ( However, the development of newer drugs like tirzepatide offer hope for improved outcomes ( To explore the role of genetic predictors, recent research pooled data from seven major lifestyle intervention trials (NUGENOB, DIOGenes, Look AHEAD, Diabetes Prevention Program, Diabetes Prevention Study, DIETFITS, PREDIMED-PLUS)
For diarrhea and constipation, it is important that patients ensure that they are having appropriate dietary fiber intake and are drinking enough water in each situation
Legal challenges emerged from the following issues: Lack of Disclosure : Allegations that manufacturers did not disclose all possible side effects
Cos X, Seidu S, Brunton S, Harris SB, Jansson SPO, Mata-Cases M, et al
S.HusainF